- Home
- / Exicure
Exicure
Stock Price
$2.6
2024-10-29
Market Capitalization
$5.6 M
2024-10-29
Revenue
$500 K
FY, 2024
Exicure Summary
Company Summary
- Overview
- Exicure is a biotechnology company developing immunomodulatory and gene regulating drugs against validated targets. Its proprietary spherical nucleic acid (SNA) architecture is designed to unlock the potential of therapeutic oligonucleotides in a range of cells and tissues. The company develops medications addressing inflammatory diseases, genetic disorders, and oncology.
- Type
- Public
- Status
- Active
- Founded
- 2011
- HQ
- Skokie, IL, US | view all locations
- Website
- http://www.exicuretx.com/
- Cybersecurity rating
- ESG rating
Table of Contents
LocationsView all
2 locations detected
Skokie, IL HQ
United States
8045 Lamon Ave #410
Chicago, IL
United States
2430 N Halsted St
Exicure Financials
Summary Financials
- Net income (FY, 2025)
- ($4.9M)
- Cash (FY, 2025)
- $3.7M
- EBIT (FY, 2025)
- ($4.2M)
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026